Lenacapavir: A Revolutionary HIV Prevention Breakthrough of 2024
Lenacapavir, a groundbreaking HIV drug developed by Gilead Sciences under the guidance of Dr. Wesley Sundquist, has been recognized as Science’s 2024 Breakthrough of the Year. Providing six months of protection, its clinical trial success marks a significant advance in HIV prevention, rendering it one of the most potent drugs available. In a groundbreaking achievement, … Read more